저자: 짐크레이머 · 외국인
요약 보기
클로락스는 실적 기대치가 낮아져 상회 가능성이 커졌으니 지금이 매수 적기라는 주장. 가이던스 하향 뒤 주가가 반등한 맥코믹 사례처럼, 클로락스도 기대치 재설정 후 상승 여지가 있다고 봄. 맥코믹은 가이던스를 두 차례 상향하며 주가가 크게 올랐음. 회사의 신규 장기전략(순매출 2~4% 성장, 영업이익률 25~50bp 개선, 풍부한 잉여현금흐름)은 시장이 과소평가하고 있으며, 주가가 훨씬 더 오를 자격이 있다고 주장. 그레그 엔더 CEO는 유통 채널 회복을 위해 소매업체와 협력 중이며 성공할 것이라고 평가. 버츠비 개인 케어 라인과 CBD 주입 제품 출시도 긍정적 요인으로 제시. 2016년과 2018년에도 우려로 주가가 급락한 바 있으나 이후 회복했음. 현 조정은 추가 하락 가능성이 있지만 매수 기회로 보며, 소액 편입 후 추가 조정 시 매수 권고. 배당수익률 2.8%도 기다리는 보상이라고 언급.
다듬은 글
so how the heck can I look at this and tell you it's time to buy the stock never lost my mind you know I think I've just done homework first of all you need to understand the Clarkes has now reset expectations I think the numbers are now low enough that they can be beaten maybe it's even classic you pot under-promise and over-deliver we've seen this pattern before you in January McCormick cut their forecasts stock got rouse then turn out to be a fabulous buying opportunity since then McCormick's raises guidance twice stock is caught fire nobody even remembers the disappointing none let's go Apple did the same thing remember when they issued that future guidance right at the beginning to your wall I mean that stocks going from 142 to 225 one of the best performers out there I think Clark's does not do the exact same thing here but that's not all see we also got some good news from the analyst day that I think no one noticed as everyone was laser focused on the number cuts for example the company rolled out a new long term strategy with new long term forecasts they're talking about two to four percent net sales growth 25 to 50 basis points of operating margin expansion and copious free cash flow generation the issue here is that most analysts just don't believe core to do it they're thinking that the targets there they're really doubting but I like the sound of the new plan they want to invest heavily in the brands and innovation to differentiate their products well a private label competitions out there that makes sense to me of course you actually live on these goals the stock deserves to go much higher that strategy makes a lot of sense to me even if course doesn't seem to be seeing a lot of benefit from it at the moment more importantly door seems to have a very good handle on what's been going wrong in the company's most troubled categories like glam bags the problem Clark's raised prices last year and everybody was worried about rising royal class then real cost came back down most of competitors left the prices unchanged in response retailers have been punishing Clorox by giving him fewer points of distribution that's the problem endure says he's working with those retailers to get that distribution back I think he's going to succeed at that oh the company also mentioned it to rolling out a line of Burt's Bees personal care I really really like this where's my Burt's Bees stuff just a second I of course don't have any Burt's Bees stuff that's my bad and that's gonna be the Burt's Bees will be actually have some in my bag not this kind though it's gonna be infused with cannabidiol or CBD and I think it'll be a big hit because it will be the first truly national trusted brand or for cannabis infused balms and salves and that's huge I mean right now Lord Jones is the big brand most people don't know where Jones but who doesn't know burst bees it for all the money the courts put behind it finally it's worth pointing out that corks has been through this before and 2016 the stock got hammered based on worries that the environment was - promotional and the private label competition - fierce the stock bottoms at 110 on November 10th of 2016 populist letters on the 38 we saw this same darn thing beginning of the last year - the stock plunged it 113 in April 2018 everyone Fred of course was a broken stock boom 167 bottle of mine when I see this kind of pull back from Clorox I don't think sell I think by although there might be more downside before it bottoms but then on door is an excellent CEO who's more than proven himself which is why he's I'm willing to stick my neck out and recommend putting a small position of cannabidiol all my putting some quarks in your portfolio and then I think you know what buy more if it pulls back because look what's coming cannabis under Burt's Bees name you tell me that won't be the bomb dalm be OMB and hey you know what they're paying you to wait with a 2.8 percent yield







Comments 0